Expression_NN
and_CC
genomic_JJ
configuration_NN
of_IN
GM-CSF_NN
,_,
IL-3_NN
,_,
M-CSF_NN
receptor_NN
-LRB-_-LRB-
C-FMS_NN
-RRB-_-RRB-
,_,
early_JJ
growth_NN
response_NN
gene-1_NN
-LRB-_-LRB-
EGR-1_NN
-RRB-_-RRB-
and_CC
M-CSF_NN
genes_NNS
in_IN
primary_JJ
myelodysplastic_JJ
syndromes_NNS
._.

Peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
from_IN
seventeen_CD
patients_NNS
with_IN
primary_JJ
myelodysplastic_JJ
syndromes_NNS
-LRB-_-LRB-
MDS_NN
-RRB-_-RRB-
in_IN
advanced_JJ
stage_NN
were_VBD
enriched_VBN
for_IN
blasts_NNS
and_CC
tested_VBN
for_IN
-LRB-_-LRB-
1_LS
-RRB-_-RRB-
karyotype_NN
,_,
-LRB-_-LRB-
2_LS
-RRB-_-RRB-
genomic_JJ
configuration_NN
and_CC
-LRB-_-LRB-
3_LS
-RRB-_-RRB-
expression_NN
of_IN
IL-3_NN
,_,
GM-CSF_NN
,_,
FMS_NN
and_CC
EGR-1_NN
genes_NNS
which_WDT
are_VBP
all_DT
located_JJ
on_IN
the_DT
long_JJ
arm_NN
of_IN
chromosome_NN
5_CD
._.

The_DT
expression_NN
of_IN
the_DT
M-CSF_NN
gene_NN
,_,
that_WDT
has_VBZ
been_VBN
recently_RB
reassigned_VBN
to_TO
the_DT
short_JJ
arm_NN
of_IN
chromosome_NN
1_CD
-LRB-_-LRB-
lp_NN
-RRB-_-RRB-
,_,
was_VBD
also_RB
investigated_VBN
._.

Aims_NNS
of_IN
the_DT
study_NN
were_VBD
to_TO
-LRB-_-LRB-
1_LS
-RRB-_-RRB-
assess_VB
the_DT
potential_JJ
role_NN
of_IN
the_DT
expression_NN
of_IN
these_DT
genes_NNS
in_IN
the_DT
maintenance_NN
and_CC
expansion_NN
of_IN
the_DT
neoplastic_JJ
clones_NNS
and_CC
-LRB-_-LRB-
2_LS
-RRB-_-RRB-
search_VB
for_IN
constitutional_JJ
losses_NNS
or_CC
rearrangements_NNS
of_IN
one_CD
allele_NN
followed_VBN
by_IN
a_DT
deletion_NN
of_IN
the_DT
second_JJ
allele_NN
of_IN
the_DT
same_JJ
genes_NNS
in_IN
the_DT
leukemic_JJ
cells_NNS
._.

The_DT
latter_JJ
issue_NN
was_VBD
investigated_VBN
by_IN
comparing_VBG
,_,
in_IN
8_CD
cases_NNS
,_,
constitutive_JJ
DNA_NN
from_IN
skin_NN
fibroblasts_NNS
with_IN
leukemic_JJ
DNA_NN
._.

Eleven_CD
of_IN
the_DT
17_CD
patients_NNS
had_VBD
abnormal_JJ
karyotypes_NNS
._.

The_DT
M-CSF_NN
gene_NN
was_VBD
expressed_VBN
in_IN
6_CD
cases_NNS
and_CC
the_DT
FMS_NN
and_CC
the_DT
EGR-1_NN
genes_NNS
were_VBD
expressed_VBN
in_IN
2_CD
of_IN
the_DT
latter_JJ
cases_NNS
._.

An_DT
autocrine_JJ
mechanism_NN
of_IN
growth_NN
could_MD
be_VB
hypothesized_VBN
only_RB
for_IN
the_DT
2_CD
patients_NNS
whose_WP$
cells_NNS
expressed_VBD
both_CC
the_DT
M-CSF_NN
and_CC
FMS_NN
genes_NNS
._.

No_DT
germline_NN
changes_NNS
or_CC
rearrangements_NNS
were_VBD
observed_VBN
in_IN
any_DT
of_IN
the_DT
genes_NNS
studied_VBN
._.

Thus_RB
,_,
deregulation_NN
of_IN
genes_NNS
encoding_VBG
for_IN
certain_JJ
hemopoietic_JJ
growth_NN
factors_NNS
or_CC
receptors_NNS
does_VBZ
not_RB
seem_VB
to_TO
represent_VB
a_DT
major_JJ
mechanism_NN
of_IN
MDS_NN
progression_NN
._.

